Sensar™ IOL Legal

Indications: Intraocular lenses are indicated for primary implantation for the visual correction of aphakia in adults undergoing surgery for removal of a cataractous lens. Precautions: Do not resterilize the lens; do not soak or rinse the lens with any solution other than sterile saline solution; do not store lens in direct sunlight. Warnings: Surgeons should consider the risk/behavior ratio for adults with preoperative ocular pathology, including but not limited to inflammation, distorted eye, and microbial infection. Adverse Events: Adverse events that have been documented as having occurred following intraocular lens implantation include but are not limited to corneal edema, iritis, lens dislocation, hyphema, macular edema, and retinal detachment. For complete listing of precautions, warnings, and adverse events, refer to package insert. Rx Only.

The AMO ADVANCED MEDICAL OPTICS INNOVATING VISION logo, Sensar and the UNFOLDER are trademarks of Advanced Medical Optics, Inc. OptiEdge is a trademark of Ocular Sciences, Inc. All other trademarks are property of their respective owners. OptiEdge™ is produced under at least one of the following U.S. Letters Patents: Nos. 6,162,249 and 6,486,306. Likewise patents pending and foreign equivalents available on request. Sensar™ is produced under at least one of the following U.S. Letters Patents: Nos. 5,657,108; 5,877,839; 6,186,625; 6,210,005; 6,409,340; and 6,468,306. Likewise patents pending and foreign equivalents available on request. The UNFOLDER™ is produced under at least one of the following U.S. Letters Patents: Nos. 4,681,102; 5,582,613; 5,716,364; 5,735,858; 5,868,752; 5,876,407; 5,942,277; 6,083,230; and 6,093,193. Likewise patents pending and foreign equivalents available on request.

Site Terms of Use and Privacy Policy.

©2005 ADVANCED MEDICAL OPTICS, INC., Santa Ana, CA 92705 www.amo-inc.com
August 2005

Site last revised November 2005